Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
FDA Greenlights Formycon and Klinge’s Biosimilar to Eylea
Formycon AG and its licensing partner Klinge Biopharma GmbH announced the U.S. Food and Drug Administration’s (FDA) approval of FYB203/AHZANTIVE®, a biosimilar to Eylea®. FYB203/AHZANTIVE® has been approved by the FDA for the treatment of patients with Age-Related Neovascular (wet)…
Study Suggests Novel Treatment Approach for Wet AMD
A recent study conducted on mice has provided promising insights into a potential alternative treatment for the “wet” version of age-related macular degeneration (AMD). Researchers identified an enzyme, telomerase, which plays a critical role in the abnormal blood vessel growth…
Researchers Use Novel Phototherapy to Target Ocular Melanoma
Scientists from the Optics and Photonics Research Center (CePOF) in Brazil, along with collaborators from the University of Toronto and Princess Margaret Cancer Center in Canada, have achieved a significant breakthrough in cancer treatment. Their study, published in Proceedings of…
Alcon Finalizes Acquisition of BELKIN Vision
Alcon has finalized its acquisition of BELKIN Vision, marking a significant expansion of its glaucoma treatment offerings. The acquisition, valued at $81M upfront, with potential additional payments up to $385M contingent on sales milestones, includes BELKIN Vision’s innovative Direct Selective…
Roche’s Vabysmo Receives CHMP Recommendation for RVO
Roche announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the extension of marketing authorization for Vabysmo (faricimab). This recommendation includes the treatment of visual impairment…
What Is Symblepharon? | OBN
What Is Symblepharon? Symblepharon is a medical condition characterized by the adhesion of the conjunctiva, the clear membrane that covers the white part of the eye and the inside of the eyelids, to the cornea, the clear front part of…
Top 10 Ophthalmologists Who Changed the Field
Ophthalmology, the branch of medicine that deals with the diagnosis and treatment of eye-related diseases and disorders, has made great strides in the past century. The following ten individuals are among the most influential and accomplished ophthalmologists in history, each…
CHMP Issues Negative Opinion on Syfovre for Geographic Atrophy
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) delivered a negative opinion on the marketing authorization application (MAA) for Apellis Pharmaceuticals’ Syfovre (pegcetacoplan), intended for the treatment of geographic atrophy (GA). CHMP’s Assessment…
Antibiotics Help Prevent Infections in Cataract Patients
A recent study published in JAMA Ophthalmology has highlighted the effectiveness of selective intracameral antibiotics combined with 1% povidone iodine in reducing the incidence of postoperative endophthalmitis after cataract surgery. Led by Jeroen van Rooij, MD, from Rotterdam Eye Hospital,…
Novel AI Boosts Geographic Atrophy Clinical Trial Efficiency
A new artificial intelligence (AI) system developed by researchers from UCL and Moorfields Eye Hospital could potentially revolutionize the recruitment process for clinical trials aimed at treating Geographic Atrophy (GA), an advanced form of dry age-related macular degeneration (AMD) that…